Navigation Links
Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
Date:3/1/2011

dditional, recurring surgeries to create a new access which can lead to multiple complications. Up to 60 percent of all arteriovenous (AV) grafts require re-intervention after one year.(1,2) AV access failure is the most common reason for hospitalization among hemodialysis patients and can lead to anemia, infection, weight loss, jaundice, prolonged bleeding, and other serious complications.(3)

Vascugel® – Combating Inflammation and Promoting HealingPervasis' novel approach to cell therapy uses adult-differentiated allogeneic endothelial cells (donor endothelial cells with a highly targeted biologic function) embedded in a polymer matrix to enhance the body's natural healing response. The endothelium is the thin layer of cells that lines the interior surface of blood vessels in the body. Endothelial cells are critical to tissue repair and health, and have a well-understood role in regulating many of the body's healing processes, including those associated with vascular repair.

Vascugel, which utilizes Pervasis' patented endothelial cell-based platform, is placed on the outside of the blood vessel at the AV access site during the surgical intervention to create the access. The endothelial formulation in Vascugel secrete several factors that combat inflammation and promote proper vascular healing, reducing thrombosis (or clotting) and the formation of intimal hyperplasia, or a thickening of the blood vessel wall in response to injury. After approximately four to eight weeks, Vascugel is safely resorbed by the body.

Pervasis' other areas of clinical investigation include improving outcomes in patients with peripheral artery disease (PAD) following surgical procedures such as percutaneous transluminal angioplasties (PTAs) with stenting, the failures of which result in serious complications and a significant increase in medical costs. Earlier this year, Pervasis announced it has also embarked on an oncology development program using it
'/>"/>

SOURCE Pervasis Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
2. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
3. Pervasis Therapeutics to Develop Novel Cell-Based Approach to Target Tumor Environment, Prevent Cancer Recurrence
4. Pervasis Therapeutics Awarded Four Grants Under the Qualifying Therapeutic Discovery Project
5. Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
6. Mylan Receives Approval for Generic Version of Neurontin® Capsules
7. Elektas Oncology-Specific MOSAIQ Receives Complete ONC-ATCB EMR Certification
8. ViewRay Receives FDA 510(k) Marketing Clearance for Treatment Planning and Delivery Software
9. Vapotherm® Receives FDA 510(k) Clearance for Flowrest® Homecare Device
10. Delcath Systems Receives Refusal to File Letter From FDA
11. Prima BioMed Receives Regulatory Scientific Advice on CVac Phase III Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sep. 03, 2015 ... ) has announced the addition of the ... 2010-2019" report to their offering. ... totally different chemical structure from steroids which ... can also provide analgestic and antipyretic effects ...
(Date:9/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/97ztz9/investigation ) ... on China Tropisetron Market, 2010-2019" report to their ... market in the Netherlands in ... 1990s. Tropisetron got administrative protection authorized by the Chinese ... submitted application. But it is now a generic drug ...
(Date:9/2/2015)... Balloon angioplasty is a minimally invasive ... report is on global angioplasty balloons studies the ... report comprises an elaborate executive summary, which includes ... various segments and sub-segments included in the study. ... data analysis of the global angioplasty balloons market ...
Breaking Medicine Technology:China Flurbiprofen Market Investigation Report 2010-2019 2China Tropisetron (Novartis) Market Report 2015-2019 2Angioplasty Balloons Market: : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Angioplasty Balloons Market: : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3
(Date:9/3/2015)... ... September 03, 2015 , ... Hunters Creek Retrievers is ... a champion AKC Black Lab Puppy. Celebrate Fall 2015 with unlimited Free Hugs and ... family to enjoy Thanksgiving and Christmas with an extra big smile. , This ...
(Date:9/3/2015)... ... September 03, 2015 , ... A scar is an unavoidable result of incision or injury to ... body's ability to heal itself. The appearance of a scar is dependent on many factors ... and skin pigmentation. ”Many scars fade to near invisibility on their own over a period ...
(Date:9/3/2015)... ... September 03, 2015 , ... Representatives ... participating at the highly anticipated Mississippi Gulf Babypalooza on September 19, 2015. , ... over, from Gulfport, Biloxi, and beyond. We will be discussing setting up college ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... About 220,800 new cases of prostate cancer ... seven men will be diagnosed with prostate cancer during their lifetime. While only one man ... of every 10 men by age 65, according to the American Cancer Society. ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... Doctor ... the highest-regarded health professionals out there. His perspective on internal medicine keeps patients happy ... happy and healthy is important regardless of the season, but even more so in ...
Breaking Medicine News(10 mins):Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2
... the shared focus of the two newest entries in ... to Practice series. Together they address both pain management ... pain medications, acetaminophen. Both issues aim to provide readers with ... management may improve care and quality of life for older ...
... about one in five children in the United States are ... number of obese kids in this country has quadrupled. ... (bariatric surgery) on adolescents took a look at their patient ... print edition of Pediatric Blood & Cancer . They ...
... (HealthDay News) -- Women who are both overweight and smoke ... study warns. Researchers in the Netherlands looked at nearly ... other birth defects, between 1997 and 2008. Congenital means ... 300 fetuses and babies born with chromosomal abnormalities, but without ...
... Aeras announces today that the National Institute of ... States National Institutes of Health (NIH), has joined as ... of a tuberculosis vaccine candidate jointly developed by Aeras ... long history of supporting TB vaccine development. However, this ...
... , SUNDAY, Jan. 29 (HealthDay News) -- Teens ... parents don,t set rules are among the most likely to ... states violates graduated licensing laws, a new study finds. ... found that for those carrying other teen passengers, distraction and ...
... FRIDAY, Jan. 27 (HealthDay News) -- If working with your iPad ... are ways around it, a new study suggests. Researchers from ... Hospital say this type of pain can be avoided if people ... and by using cases that offer higher viewing angles. The ...
Cached Medicine News:Health News:New GSA resources lay foundation for relieving seniors' pain 2Health News:Bariatric surgery in adolescents improves obesity-related diseases within first 2 years 2Health News:When Mom-to-Be's Overweight and Smokes, Risk for Birth Defects Rises 2Health News:NIH to join multi-center clinical trial of new tuberculosis vaccine 2Health News:Teen Driver's Friends Can Be Dangerous Distraction, Studies Find 2Health News:Experts Offer Tips on Avoiding iPad-Linked Shoulder, Neck Strain 2
... The ACE-Fischer External Fixation System is ... be constructed for applications ranging from ... 17-year successful clinical history has proven ... ACE-Fischer is specifically designed for the ...
... is a low osmolar ionic dimer. ... ioxaglate meglumine, 196 mg of ioxaglate ... calcium disodium as a stabilizer. The ... in each milliliter and provides 32% ...
... an X-ray contrast medium for ... for: angiography, urography, phlebography and ... of the basal cisterns, following ... cholangio (pancreato) graphy (ERC(P)), herniography, ...
... The only MR contrast agent FDA-approved ... is a gadolinium based, IV contrast media ... and liver. OptiMARK® has convenient packaging ... contrast, packaged for efficient, problem-free delivery. You ...
Medicine Products: